Kapitalo Investimentos Ltda Purchases 41 Shares of The Cigna Group (NYSE:CI)

Kapitalo Investimentos Ltda grew its position in The Cigna Group (NYSE:CIFree Report) by 3.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,122 shares of the health services provider’s stock after acquiring an additional 41 shares during the period. Kapitalo Investimentos Ltda’s holdings in The Cigna Group were worth $336,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Sanders Capital LLC increased its holdings in shares of The Cigna Group by 1.3% in the fourth quarter. Sanders Capital LLC now owns 7,727,729 shares of the health services provider’s stock valued at $2,314,068,000 after purchasing an additional 97,277 shares in the last quarter. Morgan Stanley increased its holdings in shares of The Cigna Group by 4.7% in the third quarter. Morgan Stanley now owns 4,973,106 shares of the health services provider’s stock valued at $1,422,657,000 after purchasing an additional 225,115 shares in the last quarter. Norges Bank acquired a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $1,006,348,000. Northern Trust Corp increased its holdings in shares of The Cigna Group by 5.9% in the third quarter. Northern Trust Corp now owns 3,244,157 shares of the health services provider’s stock valued at $928,056,000 after purchasing an additional 181,385 shares in the last quarter. Finally, Parnassus Investments LLC increased its holdings in shares of The Cigna Group by 5.0% in the fourth quarter. Parnassus Investments LLC now owns 2,682,061 shares of the health services provider’s stock valued at $803,143,000 after purchasing an additional 126,598 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, CEO David Cordani sold 6,338 shares of The Cigna Group stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $355.11, for a total value of $2,250,687.18. Following the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at $123,597,455.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Elder Granger sold 1,000 shares of The Cigna Group stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $338.08, for a total value of $338,080.00. Following the sale, the director now directly owns 5,471 shares in the company, valued at $1,849,635.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani sold 6,338 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $355.11, for a total transaction of $2,250,687.18. Following the completion of the transaction, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at $123,597,455.94. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,193 shares of company stock worth $19,475,326. Company insiders own 0.70% of the company’s stock.

The Cigna Group Stock Performance

Shares of CI stock opened at $334.81 on Wednesday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market capitalization of $95.11 billion, a P/E ratio of 27.49, a price-to-earnings-growth ratio of 1.02 and a beta of 0.54. The company’s 50 day moving average price is $343.36 and its two-hundred day moving average price is $329.85. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $365.71.

The Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping the consensus estimate of $6.17 by $0.30. The firm had revenue of $57.25 billion for the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period last year, the company posted $5.41 EPS. On average, analysts expect that The Cigna Group will post 28.47 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be issued a dividend of $1.40 per share. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a yield of 1.67%. The Cigna Group’s dividend payout ratio (DPR) is currently 45.98%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Oppenheimer raised their price target on shares of The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Robert W. Baird began coverage on shares of The Cigna Group in a report on Thursday, May 30th. They set an “outperform” rating and a $388.00 target price for the company. JPMorgan Chase & Co. lifted their target price on shares of The Cigna Group from $432.00 to $435.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Wednesday, June 12th. Finally, StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $373.87.

Read Our Latest Stock Analysis on The Cigna Group

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.